Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
New EPA Rules Make It Harder To Track and Regulate Dangerous Chemicals, NY Times Reports October 25, 2017 Irvin Jackson Add Your Comments The Trump administration has made a number of controversial appointments involving individuals with close ties to industry, and a recent report published by The New York Times highlights how those officials are now walking back prior government commitments to crack down on the use of potentially hazardous chemicals in products used throughout the U.S. In January, the U.S. Environmental Protection Agency (EPA) put forward new rules designed to evaluate and regulate new chemicals, in order to help determine potential risks to public health and the environment. The new rules followed the passing of The Frank R. Lautenberg Chemical Safety for the 21st Century Act, which was signed into law by President Barack Obama on June 22, 2016, as the first update to the Toxic Substances Control Act (TSCA) since it was originally enacted in 1976. Do You Know about… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION In addition to the new “foundational” rules, the EPA also proposed three rules restricting specific high risk uses of a number of chemicals. However, according to the New York Times story, implementation and enforcement of those rules appear to be in jeopardy, due primarily to the appointment of Nancy Beck, who is a deputy director in the EPA’s toxic chemicals division. Before her appointment, Beck was an executive for the American Chemistry Council, which lobbies for the chemical industry, for five years. She has taken aim at a number of rules designed to protect the public from potentially harmful chemicals, deciding that they are too burdensome on industry. One internal EPA memo leaked to the Times details how changes she made to walk back rules on perfluorooctanoic acid (PFOA) indicates that even others inside the EPA worry that she is putting in place rules that will cause the risks of these chemicals to be underestimated, and could endanger people’s health and the environment. The report also notes that in March, EPA director Scott Pruitt, who sued the EPA 14 times on behalf of industry goals before he was appointed as its head, rejected the findings of the agency’s experts and scientists and refused to ban the pesticide chlorpyrifos, which has been linked to child developmental disabilities. The American Academy of Pediatrics called the decision “deeply disturbing.” This summer, a judge overruled Pruitt’s proposed two year delay of a rule controlling methane leaks from petroleum wells, saying that Pruitt’s actions had been capricious and arbitrary and violated the Clean Air Act. It is unclear how this new approach will affect how the agency adheres to the requirements of the chemical safety law. Many fear that the agency will simply set the bar so low as to not pose much chance of the chemicals being acted upon in any way, regardless of what is found via the science. Many of those raising concerns are current or former scientists and experts within the EPA itself. In December, the EPA announced ten chemicals it was making a priority to review, including asbestos and dioxane. When a chemical is deemed to pose an unreasonable risk the EPA must take action within two years, with the possibility of an extension to four years. Bans and phaseouts have to occur within five years of an assessment that a chemical is unreasonably dangerous. For new chemicals, the EPA must review and declare that a chemical is safe before it is allowed on the marketplace and can ban, require additional testing, or place limitations on new chemicals and their uses. Much of the funding will come from chemical manufacturer user fees. When a manufacturer wants their chemical tested, they must pay 50% of the cost if it’s already on the EPA’s agenda, or 100% if the EPA has not yet scheduled a review. They will pay fees for submitting test data, for notices of new chemicals, and other activities. Tags: Chemical, EPA More Lawsuit Stories Hair Color Lawsuit Filed Over Salon Worker’s Bladder Cancer Diagnosis March 20, 2025 Request Filed To Transfer Dozens of Roundup Lawsuits in New Jersey State Court to One Judge March 20, 2025 Lean Cuisine, Stouffer’s Frozen Meals Recalled Due to Choking Hazard from “Wood-Like Material” March 20, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Hair Color Lawsuit Filed Over Salon Worker’s Bladder Cancer Diagnosis (Posted: today) A hair dye cancer lawsuit filed by a New Jersey hairdresser claims she developed bladder cancer after 11 years of exposure. MORE ABOUT: HAIR DYE LAWSUITBrazilian Blowout Cancer Lawsuit Filed by Missouri Hair Stylists Over Exosure to Toxic Chemicals (03/11/2025)Initial Status Conference for Hair Dresser’s Bladder Cancer Lawsuit Set for May 5 (03/10/2025)Hair Stylists Bladder Cancer, Breast Cancer Risks Are Now Leading to Lawsuits Against Makers of Hair Coloring Products (02/24/2025) Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (Posted: yesterday) A federal judge has appointed the BioZorb lawyers to serve in various leadership positions during coordinated pretrial proceedings in the rapidly growing litigation, taking actions that benefit all plaintiffs pursuing a claim against Hologic. MORE ABOUT: BIOZORB LAWSUITBreast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025)BioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker (03/05/2025)Schedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court (02/21/2025) Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (Posted: 2 days ago) A federal judge is expediting Depo-Provera brain tumor lawsuits towards resolution by permitting direct filing of new claims with the MDL court and appointing numerous plaintiffs’ attorneys to leadership roles. MORE ABOUT: DEPO-PROVERA LAWSUIT75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)Depo-Provera Side Effects May Increase Risk of Rare, Severe Blood Clots, Case Report Warns (03/05/2025)Depo-Provera Injury Lawyers To Apply for Leadership Positions in MDL (03/03/2025)
Request Filed To Transfer Dozens of Roundup Lawsuits in New Jersey State Court to One Judge March 20, 2025
Lean Cuisine, Stouffer’s Frozen Meals Recalled Due to Choking Hazard from “Wood-Like Material” March 20, 2025
Hair Color Lawsuit Filed Over Salon Worker’s Bladder Cancer Diagnosis (Posted: today) A hair dye cancer lawsuit filed by a New Jersey hairdresser claims she developed bladder cancer after 11 years of exposure. MORE ABOUT: HAIR DYE LAWSUITBrazilian Blowout Cancer Lawsuit Filed by Missouri Hair Stylists Over Exosure to Toxic Chemicals (03/11/2025)Initial Status Conference for Hair Dresser’s Bladder Cancer Lawsuit Set for May 5 (03/10/2025)Hair Stylists Bladder Cancer, Breast Cancer Risks Are Now Leading to Lawsuits Against Makers of Hair Coloring Products (02/24/2025)
Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (Posted: yesterday) A federal judge has appointed the BioZorb lawyers to serve in various leadership positions during coordinated pretrial proceedings in the rapidly growing litigation, taking actions that benefit all plaintiffs pursuing a claim against Hologic. MORE ABOUT: BIOZORB LAWSUITBreast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025)BioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker (03/05/2025)Schedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court (02/21/2025)
Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (Posted: 2 days ago) A federal judge is expediting Depo-Provera brain tumor lawsuits towards resolution by permitting direct filing of new claims with the MDL court and appointing numerous plaintiffs’ attorneys to leadership roles. MORE ABOUT: DEPO-PROVERA LAWSUIT75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)Depo-Provera Side Effects May Increase Risk of Rare, Severe Blood Clots, Case Report Warns (03/05/2025)Depo-Provera Injury Lawyers To Apply for Leadership Positions in MDL (03/03/2025)